**Question:** Infliximab is directed against:

**Core Concept:** Infliximab is a monoclonal antibody that targets specific proteins involved in the inflammatory process. It is a biologic response modifier, primarily used to treat various autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.

**Why the Correct Answer is Right:** Infliximab is directed against tumor necrosis factor-alpha (TNF-alpha) enzyme. TNF-alpha is a pro-inflammatory cytokine that plays a significant role in the pathogenesis of various inflammatory disorders. By binding to TNF-alpha, infliximab inhibits its biological activities, leading to a reduction in inflammation and symptom improvement.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because infliximab does not target interleukin-6 (IL-6) or any other cytokine. Its primary action is on TNF-alpha.

B. This option is incorrect as infliximab does not target the cytokine interferon-gamma (IFN-gamma), which is involved in immune response regulation and antiviral defense.

C. This option is incorrect because infliximab is not directed against the chemokine interleukin-1 (IL-1), which plays a role in the inflammatory response and tissue damage.

D. This option is incorrect as infliximab is not directed against the cytokine interleukin-2 (IL-2), which is involved in T-cell activation and proliferation.

**Clinical Pearl:** Infliximab is a valuable therapeutic option for targeting TNF-alpha in patients with severe inflammatory conditions where conventional treatments have failed or are unsuitable. It is administered intravenously as an infusion, usually in combination with other immunosuppressive agents.

**Correct Answer:** TNF-alpha (Option C)

Infliximab is directed against tumor necrosis factor-alpha (TNF-alpha), a key player in the inflammatory response and tissue damage. By inhibiting TNF-alpha, infliximab helps alleviate inflammation and related symptoms in patients with severe inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.